Safetran’s Rhea System Secures Korean Approval for Automatic Bio-Active Molecule Enrichment!

Date:2024/11/21

Targeting dry eye treatment, corneal ulcers, and dermatological applications, Safetran’s “Rhea” Automatic Bio-Active Molecule Enrichment System(BaM) received certification from the Korean FDA on November 19, 2024, becoming the first fully automated BaM system to gain recognition in Korea!

© Copyright - Safetran BioMedical Inc.